23460 North 19th Avenue
Suite 110
Phoenix, AZ 85027
United States
928 779 4143
https://www.senestech.com
Sector(s): Basic Materials
Industry: Specialty Chemicals
Full Time Employees: 26
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Kenneth S. Siegel | CEO & Director | 329.94k | N/A | 1956 |
Mr. Thomas C. Chesterman M.B.A. | Exec. VP, CFO, Treasurer & Assistant Sec. | 279.28k | N/A | 1959 |
Dr. Steven C. Krause Ph.D. | Exec. VP of Sales & Marketing | 212.5k | N/A | 1960 |
Ms. Kim Patrice Wolin | Exec. VP of Operations & Sec. | N/A | N/A | 1955 |
Ms. Nicole Williams | Chief Strategy Officer | N/A | N/A | 1980 |
Mr. Paul M. Palz | VP & Corp. Controller | N/A | N/A | N/A |
Robert Blum | Investor Relations | N/A | N/A | N/A |
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
SenesTech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.